Trials / Completed
CompletedNCT01254929
F-18 PET Bone Scans Versus Tc-99m Bone Scans for the Diagnosis of Bone Metastases
18F-Fluoride PET Bone Scans Versus Traditional 99mTc-MDP Gamma Camera Bone Scans for the Diagnosis of Bone Metastases: a Blinded, Prospective Trial
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 299 (actual)
- Sponsor
- Seattle Nuclear Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare 18F-Fluoride PET bone scans to traditional 99mTc-MDP bone scan to determine if one is better for diagnosing bone metastases.
Detailed description
Compare the diagnostic sensitivity, specificity, and accuracy of 18F-Fluoride PET bone scans versus traditional 99mTc-MDP bone scans for detecting bone metastases. Determine if there is a significant change in clinical management between the two types of scans. Measure and compare the number of equivocal or uncertain findings that would have caused additional testing, particularly additional imaging studies, to be performed for confirmation when using 18F-Fluoride PET bone scans versus 99mTc-MDP bone scans. To quantify any adverse events resulting from either scan. To perform subgroup analyses according to cancer cell type.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | F-18 PET bone scan | Following the intravenous administration of approximately 10 mCi F-18, subjects will undergo an F-18 PET bone scan. |
| DEVICE | Tc-99m bone scan | Following the intravenous administration of approximately 30mCi Tc-99m MDP, subjects will undergo a traditional bone scan on a gamma camera. |
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2014-02-01
- Completion
- 2020-03-01
- First posted
- 2010-12-07
- Last updated
- 2020-03-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01254929. Inclusion in this directory is not an endorsement.